دورية أكاديمية

Cryo-EM structures of Trypanosoma brucei gambiense ISG65 with human complement C3 and C3b and their roles in alternative pathway restriction.

التفاصيل البيبلوغرافية
العنوان: Cryo-EM structures of Trypanosoma brucei gambiense ISG65 with human complement C3 and C3b and their roles in alternative pathway restriction.
المؤلفون: Sülzen H; Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo namesti 542/2, 16000, Prague, Czech Republic.; Faculty of Science, Charles University, Albertov 6, 12800, Prague 2, Czech Republic., Began J; Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo namesti 542/2, 16000, Prague, Czech Republic.; Department of Immunobiology, University of Lausanne, Chemin des Boveresses 155, 1066, Epalinges, Switzerland., Dhillon A; Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo namesti 542/2, 16000, Prague, Czech Republic., Kereïche S; Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo namesti 542/2, 16000, Prague, Czech Republic.; First Faculty of Medicine, Charles University, Albertov 4, 12800, Prague, Czech Republic., Pompach P; Institute of Biotechnology of the Czech Academy of Sciences, 25250, Vestec, Czech Republic., Votrubova J; Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo namesti 542/2, 16000, Prague, Czech Republic., Zahedifard F; Department of Parasitology, Faculty of Science, Charles University Prague, Biocev, 25250, Vestec, Czech Republic., Šubrtova A; Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo namesti 542/2, 16000, Prague, Czech Republic., Šafner M; Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo namesti 542/2, 16000, Prague, Czech Republic., Hubalek M; Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo namesti 542/2, 16000, Prague, Czech Republic., Thompson M; Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo namesti 542/2, 16000, Prague, Czech Republic.; University of Antwerp, Antwerp, Belgium.; Agidens, Industrial Machinery Manufacturing, Zwijndrecht, Antwerp, Belgium., Zoltner M; Department of Parasitology, Faculty of Science, Charles University Prague, Biocev, 25250, Vestec, Czech Republic., Zoll S; Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo namesti 542/2, 16000, Prague, Czech Republic. sebastian.zoll@uochb.cas.cz.
المصدر: Nature communications [Nat Commun] 2023 Apr 27; Vol. 14 (1), pp. 2403. Date of Electronic Publication: 2023 Apr 27.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
أسماء مطبوعة: Original Publication: [London] : Nature Pub. Group
مواضيع طبية MeSH: Complement C3*/metabolism , Trypanosoma brucei gambiense*/metabolism, Humans ; Complement Activation ; Complement C3-C5 Convertases/metabolism ; Complement C5/metabolism ; Complement Pathway, Alternative ; Cryoelectron Microscopy ; Protein Binding
مستخلص: African Trypanosomes have developed elaborate mechanisms to escape the adaptive immune response, but little is known about complement evasion particularly at the early stage of infection. Here we show that ISG65 of the human-infective parasite Trypanosoma brucei gambiense is a receptor for human complement factor C3 and its activation fragments and that it takes over a role in selective inhibition of the alternative pathway C5 convertase and thus abrogation of the terminal pathway. No deposition of C4b, as part of the classical and lectin pathway convertases, was detected on trypanosomes. We present the cryo-electron microscopy (EM) structures of native C3 and C3b in complex with ISG65 which reveal a set of modes of complement interaction. Based on these findings, we propose a model for receptor-ligand interactions as they occur at the plasma membrane of blood-stage trypanosomes and may facilitate innate immune escape of the parasite.
(© 2023. The Author(s).)
References: Nat Microbiol. 2018 Aug;3(8):932-938. (PMID: 29988048)
Nucleic Acids Res. 2007 Jul;35(Web Server issue):W375-83. (PMID: 17452350)
PLoS Pathog. 2013;9(4):e1003317. (PMID: 23637606)
Nature. 2021 Aug;596(7873):583-589. (PMID: 34265844)
Ann N Y Acad Sci. 1983;421:291-8. (PMID: 6586103)
Commun Biol. 2019 Jun 19;2:218. (PMID: 31240256)
J Immunol. 1988 Dec 1;141(11):3895-901. (PMID: 3183384)
Blood. 2021 Jan 28;137(4):443-455. (PMID: 33507296)
Parasitology. 1975 Dec;71(3):393-417. (PMID: 645)
Mol Cell Proteomics. 2016 Aug;15(8):2730-43. (PMID: 27250206)
Front Immunol. 2019 Apr 04;10:703. (PMID: 31019515)
Cell. 2007 Nov 2;131(3):505-15. (PMID: 17981118)
Trans R Soc Trop Med Hyg. 1973;67(4):501-16. (PMID: 4206525)
Immunol Rev. 2016 Nov;274(1):33-58. (PMID: 27782325)
Biochemistry. 2001 May 22;40(20):5931-41. (PMID: 11352728)
Infect Immun. 1986 Apr;52(1):223-9. (PMID: 3633873)
Anal Chem. 2015 Jul 7;87(13):6681-7. (PMID: 25993527)
Nature. 2003 Mar 6;422(6927):83-7. (PMID: 12621437)
Nature. 2006 Nov 9;444(7116):213-6. (PMID: 17051160)
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):355-67. (PMID: 21460454)
Nature. 2013 Sep 19;501(7467):430-4. (PMID: 23965626)
J Biol Chem. 2015 Jan 23;290(4):2334-50. (PMID: 25488663)
Acta Crystallogr D Biol Crystallogr. 2006 Oct;62(Pt 10):1243-50. (PMID: 17001101)
Nat Methods. 2017 Mar;14(3):290-296. (PMID: 28165473)
Mol Reprod Dev. 2015 Jul-Aug;82(7-8):518-29. (PMID: 26153368)
Nat Commun. 2022 Aug 29;13(1):5085. (PMID: 36038546)
Eukaryot Cell. 2013 Feb;12(2):330-42. (PMID: 23264644)
Parasite Immunol. 1983 Sep;5(5):491-8. (PMID: 6634218)
FASEB J. 2018 Jan;32(1):123-129. (PMID: 28855277)
Nat Microbiol. 2018 Mar;3(3):295-301. (PMID: 29358741)
Proc Natl Acad Sci U S A. 1978 Jul;75(7):3450-4. (PMID: 210461)
Nature. 2005 Sep 22;437(7058):505-11. (PMID: 16177781)
Indian J Hematol Blood Transfus. 2021 Jan;37(1):140-146. (PMID: 33707847)
Front Immunol. 2015 Jun 02;6:262. (PMID: 26082779)
Mol Immunol. 1987 Jul;24(7):707-13. (PMID: 2443842)
Anal Chem. 2010 Jun 1;82(11):4648-51. (PMID: 20465224)
BMC Biol. 2015 Nov 09;13:93. (PMID: 26552476)
IUCrJ. 2015 Feb 26;2(Pt 2):207-17. (PMID: 25866658)
Proc Natl Acad Sci U S A. 2013 Jan 29;110(5):1905-10. (PMID: 23319650)
PLoS Negl Trop Dis. 2013;7(2):e2087. (PMID: 23469310)
J Cell Biochem. 1984;24(1):79-90. (PMID: 6725422)
Methods Mol Biol. 2015;1266:171-84. (PMID: 25560075)
Nat Rev Microbiol. 2009 Nov;7(11):775-86. (PMID: 19806154)
Infect Immun. 1993 Nov;61(11):4540-5. (PMID: 8406850)
Parasitol Today. 1994 Feb;10(2):80-4. (PMID: 15275508)
Nat Microbiol. 2019 Dec;4(12):2074-2081. (PMID: 31636418)
Front Immunol. 2020 Mar 31;11:530. (PMID: 32296436)
J Struct Biol. 2005 Oct;152(1):36-51. (PMID: 16182563)
J Immunol Methods. 1989 Aug 15;122(1):105-13. (PMID: 2760472)
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32. (PMID: 15572765)
J Appl Crystallogr. 2021 Feb 01;54(Pt 1):343-355. (PMID: 33833657)
Acta Crystallogr D Struct Biol. 2019 Oct 1;75(Pt 10):861-877. (PMID: 31588918)
Front Immunol. 2016 Jun 24;7:233. (PMID: 27446070)
PLoS Negl Trop Dis. 2012;6(7):e1728. (PMID: 22802982)
Elife. 2018 Nov 09;7:. (PMID: 30412051)
Curr Protoc Cytom. 2010 Jul;Chapter 10:Unit10.17. (PMID: 20578106)
J Mol Biol. 1990 Nov 5;216(1):141-60. (PMID: 2231728)
J Exp Med. 1981 Sep 1;154(3):856-67. (PMID: 6912277)
Nat Microbiol. 2017 Nov;2(11):1523-1532. (PMID: 28894098)
Science. 2015 Mar 27;347(6229):1470-3. (PMID: 25814582)
Nat Commun. 2020 Mar 12;11(1):1326. (PMID: 32165615)
Curr Protoc Immunol. 2001 May;Chapter 13:13.3.1-13.3.16. (PMID: 18432716)
Nat Commun. 2018 Dec 14;9(1):5316. (PMID: 30552328)
Nat Commun. 2014 Nov 20;5:5487. (PMID: 25410714)
Mol Biochem Parasitol. 1984 Sep;13(1):67-81. (PMID: 6083452)
Front Immunol. 2018 Jul 23;9:1691. (PMID: 30083158)
المشرفين على المادة: 0 (Complement C3)
EC 3.4.21.- (Complement C3-C5 Convertases)
0 (Complement C5)
0 (C3 protein, human)
تواريخ الأحداث: Date Created: 20230427 Date Completed: 20230508 Latest Revision: 20230508
رمز التحديث: 20230509
مُعرف محوري في PubMed: PMC10140031
DOI: 10.1038/s41467-023-37988-7
PMID: 37105991
قاعدة البيانات: MEDLINE
الوصف
تدمد:2041-1723
DOI:10.1038/s41467-023-37988-7